Seven Fleet Capital Management »

Belite Bio shares owned by Seven Fleet Capital Management

Quarter-by-quarter ownership of Belite Bio (BLTE) shares owned by Seven Fleet Capital Management from 13F filings

Historical chart of Seven Fleet Capital Management investment in Belite Bio

Tip: Access up to 7 years of quarterly data

All positions including Belite Bio held by Seven Fleet Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Belite Bio by Seven Fleet Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.5M 9.2k 159.96

More positions owned by Seven Fleet Capital Management

Cg Oncology (CGON)
Soleno Therapeutics (SLNO)
Revolution Medicines (RVMD)
Liquidia Corporation Com New (LQDA)
Compass Therapeutics (CMPX)
Exelixis (EXEL)
Axsome Therapeutics (AXSM)
Tyra Biosciences (TYRA)
Cogent Biosciences (COGT)
Tango Therapeutics (TNGX)
Xencor (XNCR)
Pharvaris N V (PHVS)
Terns Pharmaceuticals (TERN)
Belite Bio Sponsored Ads (BLTE)
Dyne Therapeutics (DYN)

View all positions for Seven Fleet Capital Management

Top funds holding Belite Bio

Darwin Global Management
RA Capital Management
Rtw Investments
Eventide Asset Management
Point72 Asset Management
Deerfield Management Company
Marshall Wace
UBS Group
MPM Oncology Impact Management
Holocene Advisors
Western Standard
Perceptive Advisors
Goldman Sachs Group
Soleus Capital Management
ADAR1 Capital Management

View all funds holding Belite Bio